Bavarian Nordic Reports Positive Topline Data for Mpox/Smallpox Vaccine in Pediatric Population [Yahoo! Finance]
BAVARIAN NORDIC R/I S/ADR (BVNRY)
NASDAQ:AMEX Investor Relations:
bavarian-nordic.com/investor.aspx
Company Research
Source: Yahoo! Finance
Primary endpoint was met in clinical study, demonstrating a comparable safety profile and a non-inferior immune response for MVA-BN in children aged 2-11 years compared to adults. Results will support filing for label extension with EMA in 2026. COPENHAGEN, Denmark, October 7, 2025 – Bavarian Nordic A/S (OMX: BAVA) today reported topline results from a clinical study of its MVA-BN ® mpox/smallpox vaccine in children 2 to 11 years of age. The study ( NCT06549530 ) enrolled 460 individuals in two cohorts: children aged 2-11 years and adults aged 18-50 years with the purpose of comparing safety and immunogenicity of two standard doses of the MVA-BN vaccine between the pediatric and the adult populations. The study was co-funded by the Coalition for Epidemic Preparedness Innovations (CEPI) and was conducted at sites in the Democratic Republic of Congo (DRC) and Uganda. Topline results from the study, comprising 451 individuals evaluable for the primary endpoint, showed that the i
Show less
Read more
Impact Snapshot
Event Time:
BVNRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BVNRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BVNRY alerts
High impacting BAVARIAN NORDIC R/I S/ADR news events
Weekly update
A roundup of the hottest topics
BVNRY
News
- Should You Reassess Bavarian Nordic After Vaccine Pipeline and Share Price Drop? [Yahoo! Finance]Yahoo! Finance
- Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025 in Copenhagen [Yahoo! Finance]Yahoo! Finance
- Bavarian Nordic A/S (BVNRY) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Bavarian Nordic Announces Interim Results for the First Nine Months of 2025 [Yahoo! Finance]Yahoo! Finance
- Bavarian Nordic Announces Changes to the Board of Directors [Yahoo! Finance]Yahoo! Finance